A real-world study of active vitamin D as a prognostic marker in patients with sarcoma
The variation of serum 1,25(OH)<sub>2</sub>D<sub>3</sub> can predict the disease status of patients with sarcoma. Decreased serum 1,25(OH)<sub>2</sub>D<sub>3</sub> levels are indicative of disease progression in sarcoma patients, suggesting its potential for application as a prognostic marker for disease assessment in this patient population.
Authors
- Yuhong Zhou (ORCID: https://orcid.org/0000-0001-6333-8226)
- Lingyun Zhang (ORCID: https://orcid.org/0000-0001-5733-1810)
- Xiao Wang (ORCID: https://orcid.org/0000-0002-7748-5670)
- Shan Yu
- Rongyuan Zhuang (ORCID: https://orcid.org/0000-0002-2787-6446)
- Wei Li (ORCID: https://orcid.org/0009-0001-8671-6362)
Institutions
- Sun Yat-sen University (CN)
- Fudan University (CN)
- Zhongshan Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- YangPu Geriatric Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2024-08-29
- DOI
- https://doi.org/10.1007/s12672-024-01152-4
- Primary Topic
- Vitamin D Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shanghai Municipal Health Commission